Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of metabolic disorders. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://agneskltg440461.luwebs.com/39753215/semaglutide-a-potential-solution-for-metabolic-disorders